第一作者机构：[1]Shandong First Med Univ Jinan, Shandong Canc Hosp & Inst, Rare Tumors Dept, Shandong, Peoples R China[2]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China[3]Shandong Canc Hosp & Inst, Rare Tumors Dept, Jinan, Peoples R China
推荐引用方式(GB/T 7714)：
Liu Zengjun,Xiao Yang,Xu Jing,et al.Systemic bevacizumab for aggressive recurrent respiratory papillomatosis: A single center experience of five cases[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA：
Liu, Zengjun,Xiao, Yang,Xu, Jing&Zhu, Dongyuan.(2022).Systemic bevacizumab for aggressive recurrent respiratory papillomatosis: A single center experience of five cases.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Liu, Zengjun,et al."Systemic bevacizumab for aggressive recurrent respiratory papillomatosis: A single center experience of five cases".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)
医学